These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18793395)

  • 21. [Diagnostic use of positron emission tomography in France: from the coincidence gamma-camera to mobile hybrid PET/CT devices].
    Talbot JN
    Bull Acad Natl Med; 2010 Nov; 194(8):1559-76; discussion 1576-9. PubMed ID: 22046717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear medicine studies of the prostate, testes, and bladder.
    Jana S; Blaufox MD
    Semin Nucl Med; 2006 Jan; 36(1):51-72. PubMed ID: 16356796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current imaging paradigms in radiation oncology.
    Apisarnthanarax S; Chao KS
    Radiat Res; 2005 Jan; 163(1):1-25. PubMed ID: 15606303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INVITED REVIEW--IMAGE REGISTRATION IN VETERINARY RADIATION ONCOLOGY: INDICATIONS, IMPLICATIONS, AND FUTURE ADVANCES.
    Feng Y; Lawrence J; Cheng K; Montgomery D; Forrest L; Mclaren DB; McLaughlin S; Argyle DJ; Nailon WH
    Vet Radiol Ultrasound; 2016; 57(2):113-23. PubMed ID: 26777133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of adaptive and functional imaging modalities in radiation therapy: approach and application from a radiation oncology perspective.
    Yoo DS; Wong TZ; Brizel DM
    Semin Ultrasound CT MR; 2010 Dec; 31(6):444-61. PubMed ID: 21147372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorodeoxyglucose-PET for Ablation Treatment Planning, Intraprocedural Monitoring, and Response.
    Kishore SA; Drabkin MJ; Sofocleous CT
    PET Clin; 2019 Oct; 14(4):427-436. PubMed ID: 31472740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET imaging of inflammation biomarkers.
    Wu C; Li F; Niu G; Chen X
    Theranostics; 2013; 3(7):448-66. PubMed ID: 23843893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualization, imaging and new preclinical diagnostics in radiation oncology.
    Cyran CC; Paprottka PM; Eisenblätter M; Clevert DA; Rist C; Nikolaou K; Lauber K; Wenz F; Hausmann D; Reiser MF; Belka C; Niyazi M
    Radiat Oncol; 2014 Jan; 9():3. PubMed ID: 24387195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting a new PET/CT system.
    Madsen MT
    J Am Coll Radiol; 2004 May; 1(5):356-8. PubMed ID: 17411602
    [No Abstract]   [Full Text] [Related]  

  • 30. PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.
    Tomasi G; Rosso L
    Curr Opin Pharmacol; 2012 Oct; 12(5):569-75. PubMed ID: 22901680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
    Wagenaar DJ; Kapusta M; Li J; Patt BE
    Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with the first combined positron emission tomography/computed tomography scanner in Australia.
    Lau WF; Binns DS; Ware RE; Ramdave S; Cachin F; Pitman AG; Hicks RJ
    Med J Aust; 2005 Feb; 182(4):172-6. PubMed ID: 15720173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated PET/CT and cancer imaging.
    De Wever W; Coolen J; Verschakelen JA
    JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional anatomic imaging in radiation therapy planning.
    Brunetti J; Caggiano A; Vialotti C
    Cancer J; 2004; 10(4):214-20. PubMed ID: 15383202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic imaging with FDG: a primer.
    Delbeke D; Martin WH
    Cancer J; 2004; 10(4):201-13. PubMed ID: 15383201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET/CT a hybridic equipment based on PET studies.
    Zissimopoulos A
    Hell J Nucl Med; 2007; 10(3):182. PubMed ID: 18273957
    [No Abstract]   [Full Text] [Related]  

  • 37. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NCRP 54th Annual Meeting, Radiation Protection Responsibility in Medicine: Nuclear Medicine and Radiation Oncology Q&A (Questions for Frederic H. Fahey, Melissa C. Martin, George sgouros, and Bruce Thomadsen).
    Held K
    Health Phys; 2019 Feb; 116(2):205-206. PubMed ID: 30585964
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
    Allott L; Aboagye EO
    Mol Pharm; 2020 Jul; 17(7):2245-2259. PubMed ID: 32433888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.